Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

platinum-sensitive relapsed ovarian cancer

  • You have access
    Relationship Between Hematological Toxicities During Maintenance Treatment and During Chemotherapy Before Maintenance Treatment in Patients With Platinum-sensitive Relapsed Ovarian Cancer
    HIROFUMI MATSUOKA, KEIICHIRO NAKAMURA, MASAE YORIMITSU, MARIKO OGAWA, MIHO KANEMORI, KOTARO SUEOKA, AYUMI KOZAI, HIROKO NAKAMURA, TOMOKO HARUMA, YUKO SHIROYAMA, YUU HAYATA, HIROKAZU SUGII, AKIKO UEDA, SHUICHI KURIHARA, SAIKO URAYAMA, MIYUKI SHIMIZU and HISASHI MASUYAMA
    Anticancer Research August 2023, 43 (8) 3653-3658; DOI: https://doi.org/10.21873/anticanres.16546
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire